Patient Burden and Real-World Management of Chemotherapy-Induced Myelosuppression: Results from an Online Survey of Patients with Solid Tumors

INTRODUCTION: Chemotherapy-induced myelosuppression (CIM) is one of the most common dose-limiting complications of cancer treatment, and is associated with a range of debilitating symptoms that can significantly impact patients’ quality of life. The purpose of this study was to understand patients’...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Adv Ther
Autores principales: Epstein, Robert S., Aapro, Matti S., Basu Roy, Upal K., Salimi, Tehseen, Krenitsky, JoAnn, Leone-Perkins, Megan L., Girman, Cynthia, Schlusser, Courtney, Crawford, Jeffrey
Formato: Artigo
Lenguaje:Inglês
Publicado: Springer Healthcare 2020
Materias:
Original Research
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7340862/
https://ncbi.nlm.nih.gov/pubmed/32642965
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12325-020-01419-6
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares